β-Cyclodextrin-based supramolecular nanoparticles: a pH-sensitive nanocarrier for the sustained release of the anti-tumor drug

Bi-Lian Li,Chun-Lei Wang,Qin Wang,Shao-Ming Chi,Jian-Chong Chen,Jin Zhang,Yan Zhao,Jianmei Yang
DOI: https://doi.org/10.1039/d2nj02894h
IF: 3.3
2022-10-22
New Journal of Chemistry
Abstract:Chemotherapy is one of the effective ways to treat cancer because of its ability to control lesions quickly. However, chemotherapy can have many side effects due to chemotherapy indiscriminately killing cancer cells as well as normal cells. Targeted chemotherapy strategies may be able to improve this problem effectively. In this work, a pH-responsive nanoparticle based on sulfobutyl ether-β-CD (SBE7-β-CD) and cetylbenzyldimethylammonium chloride (HDBAC) were designed and prepared. The obtained nanoparticles showed assemble and disassemble behaviors with the pH alternating between 10.0 and 2.0, which were adopted to encapsulate and release the anti-tumor drug celastrol (CSL). Moreover, CSL-loaded nanoparticles exhibited sustained release action throughout 82 h, which suggests it may possess the potential to improve therapeutic effects. In cell experiments, CSL-loaded nanoparticles displayed fewer cytotoxic effects on healthy cells, while significant cytotoxicity on five human cancer cells. Notably, CSL-loaded nanoparticles showed a higher apoptosis rate on liver cancer SMMC-7721cells than free CSL. We hope that the nanoparticles can be clinically used as a sustained-release carrier for anticancer drugs after further research.
chemistry, multidisciplinary
What problem does this paper attempt to address?